Figure 4
From: S1P Is Associated with Protection in Human and Experimental Cerebral Malaria
FTY720 treatment of ECM decreases plasma IFNγ and TNF. (A) TNF plasma levels trended toward a decrease in the plasma of all animals treated with FTY720 (P > 0.05, ANOVA, three pooled IE, n ≥ 5/group/IE). (B) IFNγ plasma levels were decreased in the plasma of animals treated with FTY720 1 d before infection and 3 d p.i. (P < 0.01 and P < 0.5 respectively, KW and DMC, three pooled IE, n ≥ 5/group/IE).